Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179623 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sophia M Villa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 1030, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Chalcones. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas, CPRIT South Texas Center of Excellence in Cancer Research, Robert A. Welch Foundation.
Abstract (Originalsprache)
Chalcones have been utilized for centuries as foods and medicines across various cultures and traditions worldwide. This paper concisely overviews their biosynthesis as specialized metabolites in plants and their significance, potential, efficacy, and possibility as future medicines. This is followed by a more in-depth exploration of naturally occurring chalcones and their corresponding mechanisms of action in human bodies. Based on their mechanisms of action, chalcones exhibit many pharmacological properties, including antioxidant, anti-inflammatory, anticancer, antimalarial, antiviral, and antibacterial properties. Novel naturally occurring chalcones are also recognized as potential antidiabetic drugs, and their effect on the GLUT-4 transporter is investigated. In addition, they are examined for their anti-inflammatory effects, focusing on chalcones used for future pharmaceutical utilization. Chalcones also bind to specific receptors and toxins that prevent bacterial and viral infections. Chalcones exhibit physiological protective effects on the biological degradation of different systems, including demyelinating neurodegenerative diseases and preventing hypertension or hyperlipidemia. Chalcones that are/were in clinical trials have been included as a separate section. By revealing the many biological roles of chalcones and their impact on medicine, this paper underlines the significance of naturally occurring chalcones and their extension to patient care, providing the audience with an index of topic-relevant information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 1030, Boston, MA 02115, USA.
- School of Medicine (SOM), University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
- School of Integrative Biological and Chemical Sciences (SIBCS), University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
- School of Earth, Environmental, and Marine Sciences (SEEMS), University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
ORCID-Profile: Sophia M Villa, Debasish Bandyopadhyay
Förderung
- Cancer Prevention and Research Institute of Texas
- CPRIT South Texas Center of Excellence in Cancer Research
- Robert A. Welch Foundation
Zitieren
APA
Villa, S. M., Heckman, J., & Bandyopadhyay, D. (2024). Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179623
Vancouver
Villa SM, Heckman J, Bandyopadhyay D. Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179623
BibTeX
@article{Villa2024,
author = {Villa, Sophia M and Heckman, Justin and Bandyopadhyay, Debasish},
title = {Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179623}
}
EUVIMED